Table 2.
Demographic and Clinical Characteristics of Vaccinated Nursing Home Residents by Previous SARS-CoV-2 Status
| No Previous SARS-CoV-2 Diagnosis or Positive Test |
Previous SARS-CoV-2 Diagnosis or Positive Test With Symptoms |
Previous SARS-CoV-2 Diagnosis or Positive Test Without Symptoms |
P-value∗ | ||||||
|---|---|---|---|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | |||||||
| Long-stay (> 100 days) | 14,681 | (73.2) | 8072 | (63.8) | 5107 | (94.8) | 1502 | (74.5) | <.01 |
| Short-stay (≤ 100 days) | 5380 | (26.8) | 4587 | (36.2) | 278 | (5.2) | 515 | (25.5) | |
| Sex | <.01 | ||||||||
| Male | 7973 | (38.1) | 5156 | (39.2) | 2038 | (36.3) | 779 | (36.5) | |
| Female | 12,938 | (61.9) | 8001 | (60.8) | 3579 | (63.7) | 1358 | (63.5) | |
| Age group, y | .01 | ||||||||
| <65 | 3874 | (18.5) | 2494 | (19.0) | 1027 | (18.3) | 353 | (16.5) | |
| 65–74 | 4891 | (23.4) | 3037 | (23.1) | 1379 | (24.6) | 475 | (22.2) | |
| 75–84 | 5918 | (28.3) | 3719 | (28.2) | 1602 | (28.5) | 597 | (27.9) | |
| ≥ 85 | 6235 | (29.8) | 3913 | (29.7) | 1609 | (28.6) | 713 | (33.4) | |
| Race/Ethnicity | |||||||||
| Black | 2551 | (12.2) | 1533 | (11.7) | 764 | (13.6) | 254 | (11.9) | <.01 |
| Hispanic | 980 | (4.7) | 566 | (4.3) | 298 | (5.3) | 116 | (5.4) | <.01 |
| Comorbidities | |||||||||
| COPD | 5614 | (27.1) | 3441 | (26.5) | 1660 | (29.7) | 513 | (24.3) | <.01 |
| Dementia | 9232 | (44.6) | 5336 | (41.1) | 2870 | (51.3) | 1026 | (48.5) | <.01 |
| Coronary artery disease | 5385 | (26.0) | 3366 | (25.9) | 1532 | (27.4) | 487 | (23.0) | <.01 |
| Diabetes | 8124 | (38.9) | 5054 | (38.5) | 2313 | (41.2) | 757 | (35.4) | <.01 |
| Congestive heart failure | 4944 | (23.9) | 3105 | (23.9) | 1426 | (25.5) | 413 | (19.5) | <.01 |
| Chronic kidney disease | 5714 | (27.6) | 3638 | (28.0) | 1572 | (28.1) | 504 | (23.8) | <.01 |
| Hypertension | 16,394 | (79.3) | 10175 | (78.4) | 4577 | (81.8) | 1642 | (77.7) | <.01 |
| Cognitive function scale | <.01 | ||||||||
| Cognitively intact | 6009 | (29.0) | 4152 | (31.9) | 1301 | (23.2) | 556 | (26.3) | |
| Mildly impaired | 4961 | (23.9) | 3094 | (23.7) | 1352 | (24.2) | 515 | (24.4) | |
| Moderately impaired | 6811 | (32.9) | 4034 | (31.0) | 2035 | (36.4) | 742 | (35.2) | |
| Severely impaired | 2949 | (14.2) | 1746 | (13.4) | 905 | (16.2) | 298 | (14.1) | |
| ADL score, mean (SD) | 19.2 | (5.5) | 19.0 | (5.5) | 19.7 | (5.5) | 18.6 | (5.8) | |
| ADL dependency quartile | <.01 | ||||||||
| 0–17 | 5521 | (26.4) | 3567 | (27.2) | 1330 | (23.7) | 624 | (29.3) | |
| 18–20 | 5935 | (26.8) | 3769 | (28.7) | 1273 | (22.7) | 551 | (25.8) | |
| 21–22 | 4457 | (21.4) | 2692 | (20.5) | 1301 | (23.1) | 464 | (21.7) | |
| 23–28 | 5306 | (25.4) | 3099 | (23.6) | 1711 | (30.5) | 496 | (23.2) | |
ADL, activities of daily living; COPD, chronic obstructive pulmonary disease.
Note: Includes all residents who received at least 1 dose of vaccine.
∗
Indicates χ2 test P value.